Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
about
CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritisAdipose tissue immunity and cancerBamboo vinegar decreases inflammatory mediator expression and NLRP3 inflammasome activation by inhibiting reactive oxygen species generation and protein kinase C-α/δ activationDecreased NK cell functions in obesity can be reactivated by fat mass reduction.Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).Identification of serum regression signs in infantile hemangioma.C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.Differential expression of monocyte surface markers among TB patients with diabetes co-morbiditySaturated Fatty Acid Increases Lung Macrophages and Augments House Dust Mite-Induced Airway Inflammation in Mice Fed with High-Fat DietEffects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.Age increases MCP-1 level in association with bariatric surgery operating time and metabolic risk severity.Ephedra-Treated Donor-Derived Gut Microbiota Transplantation Ameliorates High Fat Diet-Induced Obesity in Rats.Correlations of MCP-1 -2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis.A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyleMolecular basis of lateral force spectroscopy nano-diagnostics: computational unbinding of autism related chemokine MCP-1 from IgG antibodyHyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysisNFAT targets signaling molecules to gene promoters in pancreatic β-cells.Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2.Offspring subcutaneous adipose markers are sensitive to the timing of maternal gestational weight gain.γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice.Evaluation of the Effects of Some Brazilian Medicinal Plants on the Production of TNF- α and CCL2 by THP-1 Cells.Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.Adipokines, diabetes and atherosclerosis: an inflammatory association.Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production.Deficiency of myotubularin-related protein 14 influences body weight, metabolism, and inflammation in an age-dependent manner.Manganese supplementation reduces high glucose-induced monocyte adhesion to endothelial cells and endothelial dysfunction in Zucker diabetic fatty ratsEffects of bariatric surgery on adipokine-induced inflammation and insulin resistance.Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury.Interdependencies among Selected Pro-Inflammatory Markers of Endothelial Dysfunction, C-Peptide, Anti-Inflammatory Interleukin-10 and Glucose Metabolism Disturbance in Obese WomenDifferential association of plasma monocyte chemoattractant protein-1 with systemic inflammatory and airway remodeling biomarkers in type-2 diabetic patients with and without asthmaRespiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.Insulin secretagogue use and circulating inflammatory C-C chemokine levels in breast cancer patients.The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.Negative regulation of the inflammasome: keeping inflammation under control.Adipose tissue inflammation in the pathogenesis of type 2 diabetes.Innate immunity in diabetes and diabetic nephropathy.Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
P2860
Q24701793-7BA68FA2-6439-482E-B6AC-014F77D82C60Q26862654-04A970EB-79A8-49BD-BF49-3BBDE6E83E3DQ28534131-75C8C1F9-025C-4965-9013-06861A6E098BQ30316117-FA06963C-5F57-4CC1-9292-7396ECB98B87Q30357517-99BA05BD-D1C6-45A5-A4E8-8BBE7D802143Q31132948-9EFA7486-D956-4488-990D-B1299B0CE7BBQ31153322-708803C2-1D68-49AF-9A23-6504EA0B6432Q33620560-391F9A74-1056-45C0-82E2-1214221442EEQ33639211-9101C481-E73D-422B-A5C7-802AD09234B1Q33676574-8F54A500-502D-4455-9270-6B1F5E5DDD4FQ33764741-60B57F51-97FC-4A94-AB11-5AC413CF6507Q33819716-CD755EC9-45F2-4227-A510-70C67670080DQ33839421-D6F1DDD6-5907-4DAB-8270-722D3E6253E6Q33980736-664543AF-588F-4825-AB1D-369F47FA7994Q34125795-1165E684-8E91-4A03-81BB-EE18FB60EAD4Q34995989-5E6ED3E5-6C3B-4669-AC3E-AEB563A06E0EQ35036205-CC78930B-BA34-4C9A-8C94-350E873F616EQ35055005-BC415D7C-0000-4B51-B0F3-61B6C8508090Q35111874-3D17E3C7-5A03-46B5-9716-1760E04F5641Q35175098-E975F087-BC07-439B-B42E-FB89551CC7B1Q35186748-6186668B-3B4E-4CC5-9FD5-11A6BE755CAAQ35227727-A8B06362-C7F5-4FDB-9BBC-9566005C1FECQ35279021-D6A7296F-0A7D-4425-A62F-FDF96374D45BQ35502801-84B371D1-C343-4B38-BB61-B1E57B9DE601Q36241112-D31D3310-AB58-4411-8E1B-B4139065AD97Q36275415-D5A50251-2CEB-45AA-B868-EBDED1F448D2Q36393696-52AF89FF-FD54-4521-A356-666C5411DA5EQ36647332-113500D6-4ECA-4430-8D15-37FAFA0F66B3Q36915215-7B0EE7F1-40ED-40B5-9B5F-7FC375786A3FQ36980410-A26A8E03-4A96-4802-BE58-FC911C597E80Q37096903-06B57E4A-AF30-426D-8F3C-D3AE7F8862E4Q37299303-7919F760-535A-489E-AA50-6B9168447433Q37505835-D491351F-2314-462D-8B22-AC6317832909Q37601247-0631E1E6-3A28-42C4-AB87-9172F0A8100BQ37672586-F0919078-423C-4F62-A4D0-709EE9CD170CQ38102623-EC8076A7-A5F2-4E91-B9A4-4B3C07DF48ECQ38423405-FF04E05C-428E-4DCE-A01B-A43AB774C7F9Q38587715-705E1680-5AFF-44B6-9F63-5941E026D6C9Q38633495-E069CB44-51A6-46A7-917D-25E6141C1BABQ38649483-430FFF1E-1953-45B0-A9AC-6B6D33135A54
P2860
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@ast
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@en
type
label
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@ast
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@en
prefLabel
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@ast
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@en
P2860
P1433
P1476
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
@en
P2093
P2860
P356
10.1016/J.CYTO.2012.06.018
P577
2012-07-04T00:00:00Z